Konstantin Ostrovskiy is the Research Associate of the Laboratory of Drug Delivery Systems, at Drugs Technology LLC (Russia, Moscow Region, Khimki), a company producing pharmaceuticals and providing research of novel formulations. His 5 years of work in this field have been dedicated to the problems of drug delivery systems, for substances with poor water solubility and bioavailability especially. In his current role, he is an employee at the above mentioned laboratory, developing drug delivery systems, like protein complexes and polymer nanoparticles. His research interests are drug delivery systems and analytical procedures for their characterization. Prior to joining Drugs Technology LLC, he was a Junior Research Associate at Nanosystem Ltd. (Russia, Moscow), also carrying out research in the field of drug delivery systems. He completed his graduate studies at D.I. Mendeleev Russian University of Chemical Technology in Moscow, as an engineer (department of organic chemical technology, chair of pharmaceutical and cosmetic products). At present he is also working at his PhD dissertation at G.F. Gause Institute of New Antibiotics in Moscow.
Title : Development of intravenous form of rifapentine and its in vivo evaluation